反応と合成の進歩シンポジウム 発表要旨概要
第37回反応と合成の進歩シンポジウム
セッションID: 1P-34
会議情報

11:20~12:40 ポスターショートプレゼンテーション, 13:20~14:25 ポスター発表
ロペラミドのピペリジン窒素原子上置換基の変換と抗腫瘍活性との相関
波多江 典之矢野 圭悟*久次米 永子岩村 樹憲
著者情報
会議録・要旨集 フリー

詳細
抄録

Opioid analgesics, like a morphine, are widely used for severe pain of cancer. Recently, treatment with high concentration of buprenorphine and loperamide, which are opioid analogs, has been reported to induce apoptosis of human carcinoma, such as human lung cancer derived A549 cells. Both the molecular mechanisms and the required chemical structures of opioids for antitumor activity have been still unclear. Loperamide consists of two moieties, the 4-arylpiperidine unit and the N-substituent unit on piperidine. In this work, loperamide analogs, in which the N-substituents on piperidine are converted to the phenylalkyl groups, have been synthesized and tested the antitumor activities against human colon tumor derived HCT-116 cells. The N-phenylnonyl analog showed most potent inhibition of the tumor cells viability.

Fullsize Image
著者関連情報
© 2011 日本薬学会
前の記事 次の記事
feedback
Top